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Background: We report the findings of a feasibility study using information technology to search electronic primary care records
and to identify patients with possible colorectal cancer.
Methods: An algorithm to flag up patients meeting National Institute for Health and Care Excellence (NICE) urgent referral criteria
for suspected colorectal cancer was developed and incorporated into clinical audit software. This periodically flagged up such
patients aged 60 to 79 years. General practitioners (GPs) reviewed flagged-up patients and decided on further clinical
management. We report the numbers of patients identified and the numbers that GPs judged to need further review,
investigations or referral to secondary care and the final diagnoses.
Results: Between January 2012 and March 2014, 19 580 records of patients aged 60 to 79 years were searched in 20 UK general
practices, flagging up 809 patients who met urgent referral criteria. The majority of the patients had microcytic anaemia (236 (29%))
or rectal bleeding (205 (25%)). A total of 274 (34%) patients needed further clinical review of their records; 199 (73%) of these were
invited for GP consultation, and 116 attended, of whom 42 were referred to secondary care. Colon cancer was diagnosed in 10 out
of 809 (1.2%) flagged-up patients and polyps in a further 28 out of 809 (3.5%).
Conclusions: It is technically possible to identify patients with colorectal cancer by searching electronic patient records.
Colorectal cancer is the UK’s fourth most common cancer (Cancer
Research UK, 2013). Poorer survival rates have been noted in
Denmark and the UK than in other countries, partly owing to
treatment at a later stage (Gatta et al, 2003; Iversen, 2012;
Hamilton et al, 2013; Maringe et al, 2013) There are a number of
intervals in the diagnostic process, each contributing to the overall
period of time between symptom onset and treatment. There are
intervals between first experience of symptoms and consultation;
between consultation and having symptoms meeting referral
criteria; between meeting referral criteria and being referred for
diagnostic investigations; and an interval between diagnosis and
treatment (Weller et al, 2012). There is evidence that a shorter
interval between presenting with symptoms in primary care and
diagnosis is associated with improved prognosis (Tørring et al,
2011; Neal et al, 2015). Despite modest declines in the interval
between meeting referral criteria and diagnosis after the introduc-
tion of referral guidelines in 2005, one-quarter of patients meeting
National Institute for Health and Care Excellence (NICE) 2005
referral criteria experience delays of over 5 months (NICE, 2005;
Neal et al, 2014).
Prediction models show some promise in assisting earlier
identification of colorectal cancer. Recent years saw the
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development and validation of the CAPER scoring system to
identify patients with suspected colorectal cancer (Hamilton, 2009;
Marshall et al, 2011). Since then, a prediction model to determine
cumulative incidence of colorectal cancer from information
available in electronic primary care records has been developed
and validated (Collins and Altman, 2012; Hippisley-Cox and
Coupland, 2012). A number of strategies making use of such
prediction models have been proposed to reduce delays between
symptomatic presentation and diagnosis of colorectal cancer.
Desk-based risk assessment tools have been provided for use
during consultation (Hamilton et al, 2013). These tools remind
GPs that a patient’s symptoms or clinical features indicate an
increased cancer risk. A related approach in primary health-care
systems that use electronic primary care records is to use
electronic prompts. These automatically flag up patients at
the time of consultation whose symptoms or clinical features
indicate a pre-specified risk of cancer. Both of these approaches
assist GPs in identifying potential cancer symptoms in patients as
they consult.
Another strategy is to actively search electronic primary care
records for patients with symptoms or clinical features that
indicate that they meet referral criteria for colorectal cancer or a
pre-specified risk of cancer. This means that, once identified,
patients can be invited to attend the surgery for further
investigation. This approach has practical advantages over
reminders or tools used during consultation, as it identifies
patients who may have been missed previously, either because no
action was considered necessary at the time of consultation or
because the relevant clinical information was entered after the
consultation had ended, meaning that an electronic prompt would
be activated too late. However, there are challenges to implement-
ing such a strategy. Information technology must be developed to
identify the correct patients, practices must review the records of
identified patients and appropriate clinical action must be taken.
This paper reports the findings of CREDIBLE (ColoRectal
Early Diagnosis: an Information Based Local Evaluation), a
feasibility study to investigate the use of information technology
to search electronic primary care records and to identify patients
who meet NICE 2005 urgent referral criteria for suspected
colorectal cancer (NICE, 2005).
The study had several objectives. The first objective was to
produce and deploy a software algorithm in practice systems
that would identify patients meeting NICE 2005 urgent referral
criteria for suspected colorectal cancer (NICE, 2005). Process
objectives were to determine the proportion of patients identified
as meeting NICE (2005) urgent referral criteria; the proportion of
identified patients subsequently referred for investigation and to
describe the main reasons why patients might not be referred; the
final diagnoses ascribed to identified patients; and the relationship
of referral to participation in the bowel cancer screening
programme. A separate paper will report the results of interviews
investigating the acceptability of the system to participants and
to GPs.
MATERIALS AND METHODS
General practices were invited by letter and e-mail to take part in the
study and promotion by local Primary Care Trust (PCT) nurse
screening teams and the cancer leads, an article in the Primary Care
Research Network newsletter and a GP education session on
colorectal cancer. Participating general practices were in the urban
West Midlands, UK, and had access to software that could be
adapted for the study. The target population was patients aged 60 to
79 years without a previous diagnosis of colorectal cancer. Younger
patients were excluded because of their low incidence of colorectal
cancer, and older patients were excluded because co-morbidities and
contraindications to further investigation were likely to be common.
Patients agedX60 years meet NICE 2005 urgent referral criteria
if they have any of the following clinical features: diarrhoea or
looser stools for X6 weeks; rectal bleeding for X6 weeks;
haemoglobin p11 g dl 1 in men or p10 g dl 1 in women,
accompanied by iron deficiency (NICE, 2005).
In collaboration with a medical software company, MSDi
(Merck Sharp and Dohme, Hertfordshire, UK), we adapted
Clinical Manager software to enable searches on electronic primary
care records. Searches identified patients without a previous
diagnosis of colorectal cancer whose records indicated that they
met referral criteria up to 2 years before the date of the search. The
new software query was incorporated into Clinical Manager
software as part of a routine upgrade and was activated in practices
agreeing to participate in the study. This software query was run as
an add-on to existing clinical records systems.
Translation of urgent referral criteria into clinical coding
followed a previously described method and was partly informed
by a previous analysis of predictors of colorectal cancer (Marshall
et al, 2011). Six weeks of looser stools was indicated by two clinical
codes for diarrhoea or new prescriptions for anti-diarrhoeal drugs
separated by at least 35 days but fewer than 119 days, or by a single
clinical code for change in bowel habit. Rectal bleeding for 6 weeks
was indicated by a single clinical code for rectal bleeding. Iron
deficiency anaemia was indicated by appropriate haemoglobin
values accompanied by mean red cell volumes p80 fl. In addition,
patients were considered eligible for urgent referral if they had
either a positive faecal occult blood test (FOBt), an abdominal
mass or an abnormal rectal examination suggestive of a rectal
abnormality.
It was intended to run the software weekly in participating
general practices and to produce a list of patients flagged up as
meeting urgent referral criteria. As GP records do not code reasons
for referral, it was not possible to exclude patients who had already
undergone investigation for suspected cancer without checking
individual medical records. Patients who were flagged up and
reviewed once were not reviewed a second time if they were flagged
up again.
GPs were briefed by the researcher and a study pack was left for
reference. We followed this up with individual contacts, practice
visits, emails and newsletters throughout the study. Participating
practices agreed to review the list of flagged-up patients either
using their own staff or supported by a nurse seconded to the
practice and to determine whether patients had already been
referred for investigation for possible colorectal cancer; had
another diagnosis explaining their clinical features; investigation
was contraindicated or had been declined; and they needed further
review by a clinician.
Practices provided anonymised data including patients’ basic
demographic details to determine number of eligible patients and
clinical information relevant to the project, including reasons for not
investigating patients who were flagged up. Problems were logged.
Analysis. We present descriptive statistics: the incidence of flagged-
up patients, their symptoms, proportions reviewed in primary care,
proportions investigated and diagnoses. We also describe the
principal reasons given for not investigating flagged-up patients.
Comprehensive analysis of variations between practices of incidence
of flagged-up patients, symptom patterns and diagnoses of flagged-
up patients will be the subject of a future paper.
We planned to run the searches in 20 practices, covering a total
registered population ofB120 000, including 20 000 aged 60 to 79
years. It was anticipated that this could identify B1000 patients
aged 60 to 79 years who were eligible for urgent referral.
Ethical approval was granted by the NHS National Research
Ethics Service (Reference 11/WM/0404).
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RESULTS
Practices and population searched. Between January 2012 and
March 2014, records were searched electronically in 20 general
practices in Sandwell and Dudley. Practices were in relatively
deprived areas and had a mean registered population of 5522
(range 2085 to 13 996). Of the total registered population of
110 435 patients, 19 580 patients were aged 60 to 79 years. Searches
were run monthly because data were uploaded monthly from
practice records to MSDi Clinical Manager. Technical delays
meant that in some practices searches took place less frequently.
Several practices changed their clinical records systems, and as a
result new data extraction procedures needed to be developed. (For
a summary of the implementation process and problems
encountered, see Supplementary Online Material 1)
Number of patients meeting referral criteria. Of 19 580 eligible
patients, 809 (4.1%) were identified as meeting urgent referral
criteria: 416 (51.4%) were female; their average age was 69 years.
Mean age and gender distribution were similar across all 20 practices.
The first search conducted identified a backlog of prevalent
cases who had met referral criteria over the previous 2 years. These
first searches covered B39 160 person-years of follow-up,
equivalent to a mean incidence of 11.3 flagged-up patients per
1000 person-years of follow-up.
Subsequent searches were undertaken for a median of 17
months, each search identifying smaller numbers of newly incident
cases. In the 25 776 person-years of follow-up covered in
subsequent searches, the mean incidence of flagged-up patients
was 12.4 per 1000 person-years.
Microcytic anaemia, rectal bleeding and persistent diarrhoea
were the commonest clinical features resulting in patients being
flagged up. The pattern of clinical features was similar in prevalent
and newly incident cases (Table 1).
Findings after clinical review of patient records. The records of
the 809 flagged-up patients were reviewed by a clinician in each
practice (in 19 a nurse; in 1 a GP) and categorised into two groups:
(1) for further review of their records by the GP; and (2) not for
further review. Those not for further review were sub-categorised
as: either having previously been referred for investigation; or on
the basis of clinical judgment, having other reasons not to have
further review. In all, 274 (34%) of the flagged-up patients were
judged by the clinician as needing further review; a small number
of these had previously been referred or had other possible
explanations for their symptoms. Of those not for further review,
428 (53%) had previously been referred (Table 2); 107 (13%) had
other reasons not to investigate further, such as other cancers,
peptic ulcers, advanced renal disease, chronic bowel conditions,
iatrogenic or medication side effects, infections and extensive
haemorrhoids, frail patients and those receiving palliative care.
Three patients were prescribed codeine for pain relief unrelated to
bowel disease.
The most frequent clinical feature judged to require further
review was microcytic anaemia (112 cases) followed by persistent
diarrhoea (70) and rectal bleeding (52); (Table 3). There were
marked differences in the proportion of clinical features for which
patients had been referred for investigation: 89% of those who were
FOBt positive; 68% of those with rectal bleeding; 67% of those with
change in bowel habit; 35% of those with persistent diarrhoea; 40%
of those with microcytic anaemia; 38% of those with an abdominal
mass (w2 Po0.001). After excluding the 428 patients whose
previous referral precluded the need for further review, 71.9% (274
out of 381) of the remaining patients needed further review. This
proportion was very similar across all clinical features (Table 3).
Reasons for GPs deciding not to invite patients included the
patient having undergone lower gastrointestinal investigations
some years previously, a negative FOBt, the symptoms having been
present for many years and therefore cancer considered to be less
likely, symptoms having resolved, not considering that diarrhoea
or anaemia might indicate a risk of bowel cancer and patients
moving or dying since the search was undertaken.
A slightly lower proportion (30.5% (152 out of 498)) of patients
flagged up at first search (prevalent cases) needed further review
than the proportion (39.2% (122 out of 311)) flagged up at
subsequent searches (incident cases; w2 P¼ 0.002). However, in
both prevalent and incident cases, the pattern of previous referral
and decisions to undertake further clinical review in relation to
clinical features was similar.
Further investigations. Following GPs’ inspections of the records
of 274 patients flagged up as being in need of further review, it was
decided to invite 72.6% (199 out of 274) for a consultation, and not
to invite 22.6% (62 out of 274). In addition, four had died or moved
away from the area/practice, and three were considered to have more
pressing co-morbidities. We were unable to obtain information for
six patients. When grouped by their presenting symptoms, there was
only minor variation in the proportion of patients that GPs decided
to invite for consultation. However, one practice invited no patients.
Of the invited patients, 58.3% (116 out of 199) attended and
were seen by their GP; the remainder declined or did not respond
to the invitation. A similar proportion of first search (prevalent)
and subsequent search (incident) cases attended appointments
with their GPs. Of these, 36.2% (42 out of 116) were referred for
further investigation in secondary care: 33 to colorectal surgeons, 8
to gastroenterology and 1 to haematology. Of the remaining
patients, 36.7% (31 out of 116) had further investigations in
primary care (FOBt, full blood counts or both) and 37.1% (43 out
of 116) had no further investigations (Table 4). Similar proportions
of first search (prevalent) and subsequent search (incident) cases
were referred to secondary care. There was no evidence of variation
Table 1. Clinical features of patients flagged up as meeting colorectal cancer referral criteria
Clinical feature Identified in first search
(prevalent cases)
Identified in subsequent
searches (incident cases)
Total
Low haemoglobin and microcytic anaemia 146 29% 90 29% 236 29%
Rectal bleeding 118 24% 87 28% 205 25%
Diarrhoea for X6 weeks 106 21% 52 17% 158 20%
Change in bowel habit 65 13% 39 13% 104 13%
FOBt positive from bowel cancer screening a 54 11% 40 13% 94 12%
Abdominal or rectal mass b 5 1% 3 1% 8 1%
Symptoms not collected g 4 1% 0% 4 0%
Total 498 100% 311 100% 809 100%
Abbreviation: FOB¼ faecal occult blood. a includes one FOB result incorrectly recorded as positive. b no rectal masses were recorded. g not recorded by nurse reviewing patient notes.
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in referrals or in primary care investigations by presenting
symptoms. Analysis of variations in primary care investigations
using funnel plots indicated that two general practices undertook
FOBt in most patients and one undertook full blood counts in most
patients and that these variations were not consistent with chance
(See Supplementary Online Material Figures 1 and 2).
Of the 42 referrals, 29 patients underwent further investigations,
7 attended but did not undergo further investigations (2 because
they declined investigation, and 5 because symptoms had
resolved), 1 attended haematology only and 5 did not attend (1
patient denied symptoms, 2 patients had a history of non-attending
and 2 became either frail or confused).
Cancers and other diagnoses. Of the 809 patients flagged up, 1.2%
(10 out of 809) were subsequently diagnosed with colorectal cancer
(all were colon cancers): 1.0% (5 out of 498) of those flagged up in
first searches and 1.6% (5 out of 311) of subsequent searches
(Fisher’s exact test, two-tailed P¼ 0.520). This is equivalent to
incidence rates of 12.8 and 19.4 per 100 000 person-years in first and
subsequent searches, respectively. Patients who were not reviewed or
investigated further could present again to their GPs and be
investigated and diagnosed independently of this study. Colon
cancers were diagnosed in 1.8% (5 out of 274) patients whose
records were selected for GP review and in 0.9% (5 out of 535) not
selected for GP review (all because they had previously been referred
for investigation; Fisher’s exact test, two-tailed P¼ 0.320). Six colon
cancers were diagnosed in patients flagged up because of iron
deficiency anaemia and four because of rectal bleeding.
Twenty-eight patients were diagnosed with colorectal polyps,
giving a total of 38 with either colorectal polyp or cancer. For the
combined diagnosis of colorectal polyp or cancer, this is equivalent
to incidence rates of 43.4 and 81.5 per 100 000 person-years in the
first and subsequent searches. Colorectal cancer or polyp was
diagnosed in 4.7% (13 out of 274) of patients whose records were
selected for GP review and in 4.7% (25 out of 535) of patients not
selected for GP review. (w2 P¼ 0.964) Of these not for GP review, 23
patients had already been referred, 1 had subsequent new symptoms
and 1 had symptoms previously ascribed to medication side effects.
Of those judged to need GP review, colorectal cancer or polyp
was diagnosed in two patients who were not invited for a
GP consultation, in one patient who did not attend the GP
consultation, in three patients who were not referred to secondary
Table 3. Clinical features of flagged-up patients and decisions made about further clinical review
Not for further review
Clinical features For further review Previously referred Other reasons Total
FOBt positive from bowel cancer screening 7 7% 84 89% 3 3% 94 100%
Change in bowel habit 27 26% 69 66% 8 8% 104 100%
Diarrhoea for X6 weeks 70 44% 51 32% 37 23% 158 100%
Microcytic anaemia 112 47% 89 38% 35 15% 236 100%
Abdominal mass 3 38% 3 38% 2 25% 8 100%
Symptoms not collected 3 75% 1 25% 0% 4 100%
Rectal bleeding 52 25% 131 64% 22 11% 205 100%
Total 274 34% 428 53% 107 13% 809 100%
Abbreviation: FOBt¼ faecal occult blood test.
Table 2. Number of flagged-up patients identified as needing further review and reasons given why they might not need further
review
Clinician judgement about the need for
further review
Identified in first search
(prevalent cases)
Identified in subsequent
searches (incident cases)
Total
Clinician judges further review is needed
Previously referreda 10 2% 10 3% 20 2%
Other possible explanations for symptoms 5 1.0% 5 2% 10 1%
Contraindications to further investigation 1 0% 1 0.1%
Declined referral or did not attend 3 1% 3 0.4%
None of the above 137 28% 103 33% 240 30%
Clinician judges further review is not needed
Previously referreda 266 53% 162 52% 428 53%
Other possible explanations for symptoms 47 9% 17 5% 64 8%
Contraindications to further investigation 14 3% 3 1% 17 2%
Declined referral or did not attend 4 0.8% 1 0% 5 0.6%
Moved 3 1% 1 0% 4 0.5%
Died 5 1% 4 1% 9 1%
Records missing or unavailable 7 1.4% 1 0% 8 1.0%
Total 498 100% 311 100% 809 100%
Abbreviation: IQR¼ interquartile range.
aInvestigated a median of 194 days (IQR 63 to 415; n¼ 344) previous to the search.
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care and in seven of those referred to secondary care (17% of
those referred).
Of those diagnosed with either cancer or polyp, 45% (17 out of
38) were flagged up because of rectal bleeding, 29% (11 out of 38)
because of iron deficiency anaemia, 11% (4 out of 38) because they
screened FOBt positive, 9% (3 out of 38) because of change in
bowel habit and 9% (3 out of 38) because of persistent diarrhoea.
In total, 15.1% (122 out of 809) of flagged-up patients were
given at least 1 new diagnosis following CREDIBLE. This included
17 non-colorectal cancers, 33 diverticulosis or diverticulitis, 31 anal
fissures or haemorrhoids, 6 upper gastrointestinal diagnoses
(peptic ulcer or gastritis), 5 colitis or proctitis, 4 bile salts
malabsorption or irritable bowel syndrome, 2 colonic telangactasia
or angioma and 2 volvulus. There was no statistically significant
difference in the yield of new diagnoses between flagged patients
selected for GP review (12.4% (34/274)) and those not selected for
review (16.4% (88/535) (w2 P¼ 0.129)).
Time to investigation and diagnosis. Partial data were available
on the time intervals between symptoms, patients being flagged up,
review of records, GP consultation and definitive investigation in
secondary care.
For patients flagged up at first search (prevalent cases), the
median intervals (interquartile ranges and numbers) were as
follows: from search to review of patient records, 0 days (IQR: 0 to
8; n¼ 491); from search to being seen by the GP, 73 days (IQR 61
to 109, n¼ 44); and from search to secondary care investigation,
161 days (IQR: 79 to 243; n¼ 20). Median interval from symptoms
to being flagged up was 362 days (IQR: 188 to 568; n¼ 430).
For patients flagged up in subsequent searches (incident cases),
the median intervals were as follows: from search to review of
patient records, 0 days (IQR: 0 to 0; n¼ 308); from search to being
seen by GP, 45 days (IQR: 21 to 179; n¼ 34); and from search to
secondary care investigation, 71 days (IQR: 40 to 120; n¼ 16).
Median interval from symptoms and being flagged up was 53 days
(IQR: 37 to 90; n¼ 297).
A number of flagged-up patients had previous symptoms that
had already been investigated, 282 with symptoms and 80 as a result
of positive FOBt screening tests from the bowel cancer screening
programme. In comparison with the intervals observed in patients
flagged up as part of this study, median intervals from symptoms to
secondary care investigation were 18 days (IQR: 13 to 24 days) for
patients identified through FOBt screening and 40 days (IQR: 15 to
87 days) for patients with symptoms.
DISCUSSION
The software algorithm successfully flagged up patients meeting
referral criteria for suspected bowel cancer. Two-thirds of these
flagged-up patients had not previously been referred, notably those
with anaemia or persistent diarrhoea. Thirty-four per cent of
flagged-up patients were judged to require GP review; 23% were
invited for GP consultation; 14% attended a GP consultation; and
5% were referred for investigation in secondary care. Searches
identified 10 colon cancers (1.2% of the patients flagged up):
based on national incidence rates, we would expect 58 cases in the
total population searched over this period of time. Searches also
identified 28 colorectal polyps and a number of other significant
diagnoses.
A future qualitative paper will examine the process involved in
implementing our algorithm; however, implementation was not
always smooth. There was evidence that general practices lacked
capacity, skills and processes to deal with a list of patients meeting
referral criteria for suspected bowel cancer. In some general
practices, despite repeated reminders by research staff, the list of
patients selected for GP review was not reviewed for many weeks
or months. In one instance, a patient died of colorectal cancer
several months after being flagged up but before their records had
been reviewed. Some GPs expressed surprise that patients with iron
deficiency anaemia but without gastrointestinal symptoms were
eligible for investigation. GPs were unclear whether a negative
FOBt or an improvement in iron deficiency anaemia after iron
supplementation made referral unnecessary. There was no
evidence that the one-third of flagged patients selected for GP
review of their records were more likely to have colorectal cancer
or polyps than the two-thirds who were not selected. Future
implementation might consider selecting for further review all
flagged-up patients whose recent symptoms have not been
investigated. A substantial number of patients did not attend
when invited for consultation. There was variation in the process of
investigation and evidence that some practices used FOBt or full
blood counts to obviate referral. It is arguable that patients flagged
up warranted definitive investigation rather than FOBt or full
blood counts, as these are insufficiently accurate tests to rule out
cancer. Referrals were not always made to investigate the lower
gastrointestinal tract, referrals were not always urgent (via the
2-week wait pathway), some patients did not attend their
appointments and some were not investigated in secondary care
because symptoms seemed to resolve.
Table 4. Referrals and further investigations following GPs consultation
Referrals n % Further investigations n %
Referred to colorectal surgeons 33 28
Colorectal surgery referral only 28 24
Full blood count, then colorectal surgery referral 3 3
Full blood count and faecal occult blood test, then colorectal surgery
referral
2 2
Referred to gastroenterology or haematology 9 8
Gastroenterology 7 6
Gastroenterology and haematology 1 1
Haematology 1 1
Not referred: further investigations in primary care 31 27
Faecal occult blood test only 12 10
Full blood count 11 9
Full blood count and faecal occult blood test 7 6
Full blood count and faecal occult blood test–follow-up declined by
patient
1 1
Not referred: no specific investigations 43 37
Keep under review 3 3
None–not applicablea 31 27
Follow-up declined by patient 9 8
Total 116 100 116 100
Abbreviation: GPs¼general practitioners.
aIncludes one case in which the decision was taken after discussion with a colorectal surgeon and one case that had already been referred for upper, rather than lower, gastrointestinal tract
investigation
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There was also evidence of delay in investigation. Because data
were uploaded monthly, there was typically up to 2 months
between patients reporting incident symptoms and the software
flagging them up. Review of flagged-up patients by a nurse was
very prompt, but additional clinical research support was provided
for this. A median of over 2 months elapsed between incident cases
being flagged up and diagnostic investigations in secondary care.
Those flagged up in this study were investigated less promptly than
patients who had previously been investigated. Future implemen-
tation might include clear protocols for prompt referral for lower
gastrointestinal investigation.
A longer period of follow-up might elicit further important
diagnoses, particularly in those patients who were not investigated.
Overall, the study demonstrated that although it is technically
possible to identify patients with possible but uninvestigated
colorectal cancer, the present configuration of general practice is ill
suited to make use of this information. We observed a median of
only 18 days between patient identification as part of bowel cancer
screening programme and secondary care investigation. Referral
and investigation are standard practice following a positive
screening test, with clear pathways and protocols for investigation.
For active flagging up of symptomatic patients to be effective,
similar processes may need to be put in place.
The study made use of existing guidelines to identify patients for
further investigation, but since 2014 it has become possible to
undertake similar searches using the QCancer prediction model
within EMIS-Web clinical records software (Hippisley-Cox and
Coupland, 2013a, b; Hippisley-Cox, 2014). Similar efforts to
develop functionality have been shown with the Macmillan eCDS
tool on the BMJ Informatica platform (Moffat et al, 2014). A more
sophisticated prediction model, integrated with existing clinical
records software, may improve discrimination characteristics,
reduce the technical problems and shorten the interval between
symptoms and flagging up patients. However, technical improve-
ments do not address the problems of delay in investigating
flagged-up patients or inconsistency in investigation and referral.
Indeed, flagging up the risk of multiple cancers with different
investigations and referral pathways raises additional challenges.
The number of cancers, polyps and other diagnoses emerging
from the investigated patients in this study suggest that imple-
mentation of the algorithm is feasible. However, before recom-
mending widespread implementation, we need further under-
standing of the resource implications, the effects on GP practices
and on patients.
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